5h
Money Talks News on MSNFDA Approves at-Home Flu VaccineSay goodbye to doctor visits for your annual flu shot. NASA makes emergency decision over 'city-killer' asteroid heading for ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
The narrative is false that the COVID vaccine was rushed and not properly tested. It and other vaccines are safe and ...
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...
Ghana News Agency (GNA) on MSN1d
FDA leads 7 African regulators to foster trust and accelerate access to medicinesThe Ghana Food and Drugs Authority (FDA) has spearheaded a joint initiative with National Regulatory Authorities (NRAs) in ...
7d
GlobalData on MSNValneva’s chikungunya vaccine wins UK approvalValneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s MHRA, allowing the single-dose vaccine to be made ...
6d
StudyFinds on MSNPersonalized vaccines halt kidney cancer after encouraging phase 1 trialGroundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
The survey shows voters, regardless of party affiliation, still support vaccines and are concerned about the reduction in ...
Valneva’s chikungunya vaccine Ixchiq has been ... Ixchiq’s UK approval follows authorisations by the US Food and Drug Administration (FDA) in November 2023, the European Medicines Agency ...
Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results